Evogene (EVGN) — Cash Flow-to-Debt Ratio
Evogene (EVGN) has a Cash Flow-to-Debt Ratio of -0.43x as of September 2025, meaning its operating cash flow of ILA-3.79 Million could theoretically repay 0% of its total liabilities (ILA8.83 Million) in one year. See Evogene free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Evogene Cash Flow-to-Debt Ratio (2008–2024)
Historical debt coverage capacity for Evogene across 16 annual periods. Also explore Evogene (EVGN) net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Evogene (2008–2024)
Year-by-year debt coverage analysis for Evogene. For market capitalisation and broader financial context, see EVGN company net worth.
| Year | CF-to-Debt Ratio | Operating CF (ILA) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.79x | ILA-19.70 Million | ILA25.03 Million | ▲ +18.2% |
| 2023 | -0.96x | ILA-21.58 Million | ILA22.42 Million | ▲ +13.3% |
| 2022 | -1.11x | ILA-23.68 Million | ILA21.34 Million | ▲ +42.4% |
| 2021 | -1.93x | ILA-24.84 Million | ILA12.88 Million | ▼ -48.5% |
| 2020 | -1.30x | ILA-19.51 Million | ILA15.03 Million | ▲ +16.7% |
| 2019 | -1.56x | ILA-17.36 Million | ILA11.15 Million | ▲ +13.8% |
| 2018 | -1.81x | ILA-15.16 Million | ILA8.39 Million | ▲ +6.7% |
| 2017 | -1.94x | ILA-15.93 Million | ILA8.22 Million | ▼ -44.1% |
| 2016 | -1.34x | ILA-11.69 Million | ILA8.70 Million | ▲ +4.2% |
| 2015 | -1.40x | ILA-12.41 Million | ILA8.84 Million | ▼ -81.5% |
| 2014 | -0.77x | ILA-8.89 Million | ILA11.50 Million | ▼ -84.3% |
| 2013 | -0.42x | ILA-5.27 Million | ILA12.56 Million | ▼ -268.7% |
| 2012 | -0.11x | ILA-1.89 Million | ILA16.60 Million | ▼ -205.6% |
| 2011 | 0.11x | ILA2.13 Million | ILA19.80 Million | ▲ +186.2% |
| 2009 | 0.04x | ILA886.00K | ILA23.54 Million | ▼ -92.7% |
| 2008 | 0.52x | ILA12.61 Million | ILA24.34 Million | — |